Complaint
This POCT Immunoassay Quantitative Analyzer supports the reagents like Cardiac Markers, Inflammatory Markers, Inflammatory Markers and Thrombus
Advantages
·High standards: quantitative detection, multiple quality control, with the accurate and stable results
·High intelligence: automatic identification, full-automated detection with one
button, Effective docking hospital lis system and automatic uploading data
·High efficiency: real-time detection, automatic detection within 20 minutes, realizing fast batch testing
·High flexible: a variety of supplementary reagents, covering heart, inflammation, kidney and other fields
Supporting reagents and clinical application:
·Cardiac markers
Cardiac Troponin I / Myoglobin / Creatine Kinase Isoenzyme MB(cTnI/Myo/CK-MB)
Clinical application:
Early diagnosis of acute coronary syndrome;
The prognosis and risk stratification of acute coronary syndrome evaluation;
The forecast of myocardial infarction area;
The indicator of thrombolysis and interventional therapy after acute myocardial infarction;
Differential diagnosis of chest pain reasons;
The evaluation of clinical therapeutic effect.
Application department: cardiology department (outpatient clinic, and ward and CCU); emergency department (120 ambulance, ICU); Clinical laboratory, etc.
Triad detection, including cTnI, Myo and CK-MB, can effectively avoid missed diagnosis and misdiagnosis.
Heart-type fatty acid binding-protein (H-FABP)
Clinical application:
The earliest sensitive parameter of AMI diagnosis;
The forecast of myocardial infarction area;
The diagnosis and monitoring of traumatic myocardial injury;
Recent predict cardiovascular events after coronary stent.
Early detection of H-FABP and Myo, and convalescent of cTnI and CK-MB, is helpful to select high-risk patients with myocardial damage.
N-terminal pro-brain B-type natriuretic peptides(NT-proBNP)
Clinical application:
Prevention and detection of heart failure;
Monitoring and evaluation of heart failure therapy;
Diagnosis and risk stratification of heart failure;
Risk stratification of acute coronary syndrome (ACS);
Identification of heart failure and other reasons caused by breathing difficulties.
Application department: cardiology department (outpatient clinic, and ward and CCU); emergency department (120 ambulance, ICU); pneumology Department, thoracic surgery, etc.
·Inflammatory Markers
Procalcitonin(PCT)
Clinical application: The identification of bacterial and viral infections;
Identification and diagnosis of sepsis, assessment of the severity of the sepsis and disease progression, and prognosis of sepsis judgment;
Accurate guidance for the use of antibiotic, avoiding the abuse of antibiotics;
The differential diagnosis of fever infection after the surgery, radiotherapy and chemotherapy.
Application department: infections department, pediatrics, respiratory infection, emergency department, cardiology, oncology, surgical department, etc.
The use of PCT in the sepsis (ICU):
PCT< 0.5ng/ml Showing that sepsis is extremely unlikely;
PCT> 2 ng/ml Indicating that sepsis could escalate to septic shock.
1)PCT guiding the use of antibiotics
PCT< 0.1ng/ml Basic without the possibility of bacterial infection, not strongly
recommend the use of antibiotics;
PCT:0.1-0.25ng/ml Bacterial infection is unlikely, whether to use antibiotics
should combined with clinical symptoms;
PCT:0.25-0.5ng/ml There may be a need to treat bacterial infections and recommend the use of antibiotics;
PCT> 0.5 ng/ml No doubt in need of treatment of bacterial infections, strongly recommend the use of antibiotic.
C-reactive protein(hs-CRP+CRP)
Clinical application:
The identification of bacterial and viral infections;
Effect evaluation of antibiotic treatment;
The detection and postoperative monitoring in inflammatory disease;
The risk of cardiovascular disease and treatment evaluation.
Application department: Clinical laboratory, infections department, pediatrics, pneumology department, emergency department, cardiology department, surgical department, etc.
Severity judgment of conventional inflammation
CRP>50 ug/ml Serious bacterial infection;
CRP:20-50 ug/ml General bacterial infections;
CRP:10-20 ug/ml Viral or bacterial infection.
1)Cardiovascular severe judgment
hs CRP<1 ug/ml Low sick;
hs CRP :1-3 ug/ml Moderate risk;
hs CRP>3 ug/ml Highly dangerous.
Thrombus
D-Dimer
Clinical application:
Exclusion and auxiliary diagnosis of deep venous thrombosis(DVT)and pulmonary embolism(PE);
Diagnosis of disseminated intravascular coagulation(DIC);
Surgery and thrombolytic therapy monitoring;
Diagnosis and detection of high coagulation state of pregnancy-induced hypertension syndrome;
Auxiliary diagnosis and prognosis of cerebral infarction.
Application department: cardiology department, emergency department, pneumology department, neurology department, surgical department, etc.
1)Suspected deep vein thrombosis(DVT)in clinic
D-Dimer<0.5 ng/mL,Eliminating DVT;
D-Dimer>0.5 ng/mL,Perfoming ultrasonic inspection, if positive, then must be treated with DVT, if negative, considering other clinical possibilities.
2)Suspected pulmonary embolism(PE)in clinic
D-Dimer<0.5 ng/mL,Eliminating PE;
D-Dimer>0.5 ng/mL,Perfoming ultrasonic inspection, if positive, then must be treated with PE, if negative, make a definite diagnosis with ventilation/perfusion scans .
